Your browser doesn't support javascript.
loading
Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.
Woo, Janghee; Deeg, H Joachim; Storer, Barry; Yeung, Cecilia; Fang, Min; Mielcarek, Marco; Scott, Bart L.
Affiliation
  • Woo J; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Storer B; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Yeung C; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Fang M; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Mielcarek M; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Scott BL; Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington. Electronic address: bscott@fredhutch.org.
Biol Blood Marrow Transplant ; 23(1): 176-179, 2017 01.
Article in En | MEDLINE | ID: mdl-27789363

Full text: 1 Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Remission Induction / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Induction Chemotherapy Type of study: Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Remission Induction / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation / Induction Chemotherapy Type of study: Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article